The Valley Desk

NCT06132958 · Interventional trial

Sacituzumab Tirumotecan (MK-2870) in Post Platinum and Post Immunotherapy Endometrial Cancer (MK-2870-005)

Overall registry status Active not recruiting

Phase 3

Conditions Endometrial Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov